|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| A61K 39/395 | |||
| A61P 25/28 |
| (11) | Number of the document | 2593475 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11807457.4 |
| Date of filing the European patent application | 2011-07-13 | |
| (97) | Date of publication of the European application | 2013-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/043866 |
| Date | 2011-07-13 |
| (87) | Number | WO 2012/009442 |
| Date | 2012-01-19 |
| (30) | Number | Date | Country code |
| 364210 P | 2010-07-14 | US |
| (72) |
GASPAR, Renee C., US
SHUGHRUE, Paul J., US
WANG, Fubao, US
WANG, Weirong, US
ZHANG, Ningyan, US
ZHAO, Wei-Qin, US
McCAMPBELL, Alexander, US
XU, Min, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF |
| ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF |